Jeannie Hoffman-Censits

2024

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

EV-302 Trial Investigators, Mar 7 2024, In: New England Journal of Medicine. 390, 10, p. 875-888 14 p.

Research output: Contribution to journal › Article › peer-review

The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma

Hoffman-Censits, J., Grivas, P., Powles, T., Hawley, J., Tyroller, K., Seeberger, S., Guenther, S., Jacob, N., Mehr, K. T. & Hahn, N. M., Feb 1 2024, In: Future Oncology. 20, 4, p. 179-190 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2023

Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the Bladder

Agrawal, P., Rostom, M., Alam, R., Florissi, I., Biles, M., Rodriguez, K., Hahn, N. M., Johnson, B. A., Matoso, A., Smith, A., Bivalacqua, T. J., Kates, M., Hoffman-Censits, J. & Patel, S. H., Dec 2023, In: Clinical Genitourinary Cancer. 21, 6, p. 631-638.e1

Research output: Contribution to journal › Article › peer-review

Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladder

Parimi, V., Choi, W., Feng, M., Fong, M., Hoffman-Censits, J., Kates, M., Lombardo, K. A., Comperat, E., McConkey, D. J., Hahn, N. M., Esteves, R. S. & Matoso, A., Jun 2023, In: Histopathology. 82, 7, p. 991-1002 12 p.

Research output: Contribution to journal › Article › peer-review

Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

Coleman, J. A., Clark, P. E., Bixler, B. R., Buckley, D. I., Chang, S. S., Chou, R., Hoffman-Censits, J., Kulkarni, G. S., Matin, S. F., Pierorazio, P. M., Potretzke, A. M., Psutka, S. P., Raman, J. D., Smith, A. B. & Smith, L., Jun 1 2023, In: Journal of Urology. 209, 6, p. 1071-1081 11 p.

Research output: Contribution to journal › Article › peer-review

Enhancing bladder cancer care through the multidisciplinary clinic approach

Mark, J. R., Gomella, L. G., Lallas, C. D., Smentkowski, K. E., Calvaresi, A., Handley, N., Den, R. B., Mille, P., Tester, W. J., Hoffman-Censits, J., Dicker, A. P., Klonicke, E., Halpern, E., McCue, P., Kelly, W. K. & Trabulsi, E. J., 2023, In: Canadian Journal of Urology. 30, 3, p. 11526-11531 6 p.

Research output: Contribution to journal › Article › peer-review

Identification of Lineage-specific Transcriptional Factor–defined Molecular Subtypes in Small Cell Bladder Cancer

Feng, M., Matoso, A., Epstein, G., Fong, M., Park, Y. H., Gabrielson, A., Patel, S., Czerniak, B., Compérat, E., Hoffman-Censits, J., Kates, M., Kim, S., McConkey, D. & Choi, W., 2023, (Accepted/In press) In: European Urology.

Research output: Contribution to journal › Article › peer-review

2022

A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non–muscle-invasive Bladder Cancer

Choi, W., Lombardo, K., Patel, S., Epstein, G., Feng, M., Gabrielson, A., Hahn, N. M., Hoffman-Censits, J., McConkey, D., Bivalacqua, T. J., Matoso, A. & Kates, M., Feb 2022, In: European Urology. 81, 2, p. 138-142 5 p.

Research output: Contribution to journal › Article › peer-review

Bladder Cancer, Version 2.2022 Featured Updates to the NCCN Guidelines

Flaig, T. W., Spiess, P. E., Abern, M., Agarwal, N., Bangs, R., Boorjian, S. A., Buyyounouski, M. K., Chan, K., Chang, S., Friedlander, T., Greenberg, R. E., Guru, K. A., Herr, H. W., Hoffman-Censits, J., Kishan, A., Kundu, S., Lele, S. M., Mamtani, R., Margulis, V., Mian, O. Y., & 18 othersMichalski, J., Montgomery, J. S., Nandagopal, L., Pagliaro, L. C., Parikh, M., Patterson, A., Plimack, E. R., Pohar, K. S., Preston, M. A., Richards, K., Sexton, W. J., Siefker-Radtke, A. O., Tollefson, M., Tward, J., Wright, J. L., Dwyer, M. A., Cassara, C. J. & Gurski, L. A., Aug 2022, In: JNCCN Journal of the National Comprehensive Cancer Network. 20, 8, p. 866-878 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival

Patel, H. D., Patel, S. H., Blanco-Martinez, E., Kuzbel, J., Chen, V. S., Druck, A., Koehne, E. L., Patel, P. M., Doshi, C. P., Hahn, N. M., Hoffman-Censits, J. H., Berg, S., Bivalacqua, T. J., Kates, M. & Quek, M. L., Jan 1 2022, In: Journal of Urology. 207, 1, p. 77-85 9 p.

Research output: Contribution to journal › Article › peer-review

Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature

Aragaki, A. K., Jing, Y., Hoffman-Censits, J., Choi, W., Hahn, N. M., Trock, B. J., McConkey, D. J. & Johnson, B. A., Jun 1 2022, In: European Urology Oncology. 5, 3, p. 338-346 9 p.

Research output: Contribution to journal › Article › peer-review

Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma

Lyou, Y., Rosenberg, J. E., Hoffman-Censits, J., Quinn, D. I., Petrylak, D., Galsky, M., Vaishampayan, U., De Giorgi, U., Gupta, S., Burris, H., Rearden, J., Li, A., Xu, C., Andresen, C., Moran, S., Daneshmand, S., Bajorin, D., Pal, S. K. & Grivas, P., Feb 2022, In: Clinical Genitourinary Cancer. 20, 1, p. 35-42 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trials

Gabrielson, A. T., Daniels, M. J., Rowe, J., Alam, R., Lee, E. J., Matoso, A., De Felice, A., Hahn, N., Hoffman-Censits, J., Bivalacqua, T. J. & Kates, M., Apr 2022, In: Urologic Oncology: Seminars and Original Investigations. 40, 4, p. 164.e9-164.e16

Research output: Contribution to journal › Article › peer-review

Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women With Variant Histology and Advanced Stage

Patel, S. H., Wang, S., Metcalf, M. R., Gupta, N., Gabrielson, A., Lee, E., Rostom, M., Pierorazio, P., Smith, A., Hahn, N., Schoenberg, M., Kates, M., Hoffman-Censits, J. & Bivalacqua, T. J., Feb 2022, In: Clinical Genitourinary Cancer. 20, 1, p. 60-68 9 p.

Research output: Contribution to journal › Article › peer-review

Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: The phase III PROOF 302 trial

Pal, S. K., Somford, D. M., Grivas, P., Sridhar, S. S., Gupta, S., Bellmunt, J., Sonpavde, G., Fleming, M. T., Lerner, S. P., Loriot, Y., Hoffman-Censits, J., Valderrama, B. P., Andresen, C., Schnabel, M. J., Cole, S. & Daneshmand, S., Jul 2022, In: Future Oncology. 18, 21, p. 2599-2614 16 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2021

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

IMvigor010 Study Group, Apr 2021, In: The Lancet Oncology. 22, 4, p. 525-537 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer[Formula presented]

Becker, R. E. N., Meyer, A. R., Brant, A., Reese, A. C., Biles, M. J., Harris, K. T., Netto, G., Matoso, A., Hoffman-Censits, J., Hahn, N. M., Choi, W., McConkey, D., Pierorazio, P. M., Johnson, M. H., Schoenberg, M. P., Kates, M. R., Baras, A. & Bivalacqua, T. J., Mar 2021, In: European Urology. 79, 3, p. 364-371 8 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes

Hoffman-Censits, J. H., Lombardo, K. A., Parimi, V., Kamanda, S., Choi, W., Hahn, N. M., McConkey, D. J., McGuire, B. M., Bivalacqua, T., Kates, M. & Matoso, A., Sep 1 2021, In: Applied Immunohistochemistry and Molecular Morphology. 29, 8, p. 619-625 7 p.

Research output: Contribution to journal › Article › peer-review

Identification of a synthetic lethal relationship between nucleotide excision repair deficiency and irofulven sensitivity in urothelial cancer

Börcsök, J., Sztupinszki, Z., Bekele, R., Gao, S. P., Diossy, M., Samant, A. S., Dillon, K. M., Tisza, V., Spisák, S., Rusz, O., Csabai, I., Pappot, H., J. Frazier, Z., Konieczkowski, D. J., Liu, D., Vasani, N., Rodrigues, J. A., Solit, D. B., Hoffman-Censits, J. H., Plimack, E. R., & 10 othersRosenberg, J. E., Lazaro, J. B., Taplin, M. E., Iyer, G., Brunak, S., Lozsa, R., Van Allen, E. M., Szüts, D., Mouw, K. W. & Szallasi, Z., Apr 2021, In: Clinical Cancer Research. 27, 7, p. 2011-2022 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Imaging Urothelial Bladder Cancer: A VPAC PET Targeted Approach

Thakur, M. L., Tripathi, S. K., Gomella, L. G., Salmanoglu, E., Kim, S., Kelly, W. K., Keith, S. W., Intenzo, C., McCue, P., Hoffman-Censits, J. & Trabulsi, E. J., Apr 2021, In: Canadian Journal of Urology. 28, 2, p. 10596-10602 7 p.

Research output: Contribution to journal › Article › peer-review

Molecular subtypes of upper tract urothelial cancer: Setting the stage for precision therapy

McConkey, D. J., Singla, N., Pierorazio, P., Lombardo, K., Matoso, A. & Hoffman-Censits, J., Jun 14 2021, In: Cancer cell. 39, 6, p. 745-747 3 p.

Research output: Contribution to journal › Article › peer-review

Open Access

New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer – What do we understand so far?

Hoffman-Censits, J., Lombardo, K., McConkey, D., Hahn, N. M., Bashir, B., Kelly, W. K., Johnson, B. & Matoso, A., Oct 2021, In: Urologic Oncology: Seminars and Original Investigations. 39, 10, p. 619-622 4 p.

Research output: Contribution to journal › Article › peer-review

Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma

Bedke, J., Merseburger, A. S., Loriot, Y., Castellano, D., Choy, E., Duran, I., Rosenberg, J. E., Petrylak, D. P., Dreicer, R., Perez-Gracia, J. L., Hoffman-Censits, J. H., Van Der Heijden, M. S., Pavlova, J., Thiebach, L., de Ducla, S., Fear, S., Powles, T. & Sternberg, C. N., Sep 2021, In: European Urology Focus. 7, 5, p. 1084-1091 8 p.

Research output: Contribution to journal › Article › peer-review

Penile sarcomatoid urothelial carcinoma: A case report

Wang, S., Metcalf, M., Hoffman-Censits, J., Bivalacqua, T. & Patel, S. H., Sep 2021, In: Urology Case Reports. 38, 101706.

Research output: Contribution to journal › Article › peer-review

Open Access

Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma

Ghandour, R. A., Freifeld, Y., Cheaib, J., Singla, N., Meng, X., Kenigsberg, A., Bagrodia, A., Woldu, S., Hoffman-Censits, J., Enikeev, D., Rapoport, L., Petros, F. G., Raman, J. D., Pierorazio, P. M., Matin, S. F. & Margulis, V., Nov 2021, In: Urologic Oncology: Seminars and Original Investigations. 39, 11, p. 788.e15-788.e21

Research output: Contribution to journal › Article › peer-review

Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma

Cheaib, J. G., Claus, L. E., Patel, H. D., Kates, M. R., Matoso, A., Hahn, N. M., Bivalacqua, T. J., Hoffman-Censits, J. H. & Pierorazio, P. M., Jan 2021, In: Urologic Oncology: Seminars and Original Investigations. 39, 1, p. 74.e9-74.e16

Research output: Contribution to journal › Article › peer-review

Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience

Hoffman-Censits, J., Choi, W., Bivalacqua, T. J., Pierorazio, P., Kates, M., Lombardo, K., Parini, V., McConkey, D., Trabulsi, E. J., Hahn, N. & Matoso, A., Apr 2021, In: Clinical Genitourinary Cancer. 19, 2, p. 176-181 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Understanding Psychosocial and Sexual Health Concerns Among Women With Bladder Cancer Undergoing Radical Cystectomy

Gupta, N., Rasmussen, S. E. V. P., Haney, N., Smith, A., Pierorazio, P. M., Johnson, M. H., Hoffman-Censits, J. & Bivalacqua, T. J., May 2021, In: Urology. 151, p. 145-153 9 p.

Research output: Contribution to journal › Article › peer-review

Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile

Hoffman-Censits, J., Choi, W., Pal, S., Trabulsi, E., Kelly, W. K., Hahn, N. M., McConkey, D., Comperat, E., Matoso, A., Cussenot, O., Cancel-Tassin, G., Fong, M. H. Y., Ross, J., Madison, R. & Ali, S., Apr 1 2021, In: European Urology Oncology. 4, 2, p. 297-300 4 p.

Research output: Contribution to journal › Article › peer-review

Urothelial Carcinoma in Situ of the Bladder: Correlation of CK20 Expression with Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome

Lombardo, K. A., Murati Amador, B., Parimi, V., Hoffman-Censits, J., Choi, W., Hahn, N. M., Kates, M., Bivalacqua, T. J., McConkey, D., Hoque, M. O. & Matoso, A., Feb 2021, In: Applied Immunohistochemistry and Molecular Morphology. 29, 2, p. 127-135 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

2020

A Pilot Study of Radiation Therapy in Combination with Pembrolizumab in Patients with Metastatic Renal Cell Cancer

Lin, J., Song, A. J., Hoffman-Censits, J., Leiby, B. E., Tuluc, M., Shaw, C., Harshyne, L., Kean, R., Bar-Ad, V., Den, R. B., Hurwitz, M. D., Louie, J., Philipose, S., Deshmukh, S. P., Johnson, J. M., Dicker, A. P., Hooper, D. C., Kelly, W. K. & Lu, B., Feb 1 2020, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 43, 2, p. 82-86 5 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Atezolizumab in patients with renal insufficiency and mixed variant histology: Analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma

Hoffman-Censits, J., Pal, S., Kaiser, C., Ding, B. & Bellmunt, J., Jul 7 2020, In: Journal for immunotherapy of cancer. 8, 2, e000419.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Bladder cancer, version 3.2020

Flaig, T. W., Spiess, P. E., Agarwal, N., Bangs, R., Boorjian, S. A., Buyyounouski, M. K., Chang, S., Downs, T. M., Efstathiou, J. A., Friedlander, T., Greenberg, R. E., Guru, K. A., Guzzo, T., Herr, H. W., Hoffman-Censits, J., Hoimes, C., Inman, B. A., Jimbo, M., Karim Kader, A., Lele, S. M., & 15 othersMichalski, J., Montgomery, J. S., Nandagopal, L., Pagliaro, L. C., Pal, S. K., Patterson, A., Plimack, E. R., Pohar, K. S., Preston, M. A., Sexton, W. J., Siefker-Radtke, A. O., Tward, J., Wright, J. L., Gurski, L. A. & Johnson-Chilla, A., 2020, In: JNCCN Journal of the National Comprehensive Cancer Network. 18, 2, p. 329-354 26 p.

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Miron, B., Hoffman-Censits, J. H., Anari, F., O'Neill, J., Geynisman, D. M., Zibelman, M. R., Kutikov, A., Viterbo, R., Greenberg, R. E., Chen, D., Lallas, C. D., Trabulsi, E. J., Alpaugh, R. K., Dulaimi, E., Golemis, E. A., Uzzo, R., Ross, E. A. & Plimack, E. R., Aug 1 2020, In: European Urology Oncology. 3, 4, p. 544-547 4 p.

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: A multi-methods approach

Lee, C. T., Mohamed, N. E., Pisipati, S., Shah, Q. N., Agarwal, P. K., Downs, T. M., Droller, M., Gilbert, S. M., Goltz, H. H., Hall, S. J., Hendawi, M., Hoffman-Censits, J., O'Donnell, M., Kaag, M., Karsh, L. I., Kassouf, W., Quale, D. Z., Sagalowsky, A., Steinberg, G. D. & Latini, D. M., Jul 24 2020, In: BMC health services research. 20, 1, 686.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1–3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3–altered Advanced/Metastatic Urothelial Carcinoma

Lyou, Y., Grivas, P., Rosenberg, J. E., Hoffman-Censits, J., Quinn, D. I., P. Petrylak, D., Galsky, M., Vaishampayan, U., De Giorgi, U., Gupta, S., Burris, H., Rearden, J., Li, A., Wang, H., Reyes, M., Moran, S., Daneshmand, S., Bajorin, D. & Pal, S. K., Dec 2020, In: European Urology. 78, 6, p. 916-924 9 p.

Research output: Contribution to journal › Article › peer-review

Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results

Pal, S. K., Bajorin, D., Dizman, N., Hoffman-Censits, J., Quinn, D. I., Petrylak, D. P., Galsky, M. D., Vaishampayan, U., De Giorgi, U., Gupta, S., Burris, H. A., Soifer, H. S., Li, G., Wang, H., Dambkowski, C. L., Moran, S., Daneshmand, S. & Rosenberg, J. E., Jun 1 2020, In: Cancer. 126, 11, p. 2597-2606 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

16 Scopus citations

Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma

Margulis, V., Puligandla, M., Trabulsi, E. J., Plimack, E. R., Kessler, E. R., Matin, S. F., Godoy, G., Alva, A., Hahn, N. M., Carducci, M. A. & Hoffman-Censits, J., Apr 1 2020, In: Journal of Urology. 203, 4, p. 690-698 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

16 Scopus citations

Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer

Lin, J., Den, R. B., Greenspan, J., Showalter, T. N., Hoffman-Censits, J. H., Lallas, C. D., Trabulsi, E. J., Gomella, L. G., Hurwitz, M. D., Leiby, B., Dicker, A. P. & Kelly, W. K., Apr 1 2020, In: International Journal of Radiation Oncology Biology Physics. 106, 5, p. 939-947 9 p.

Research output: Contribution to journal › Article › peer-review

2018

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)

Rosenberg, J. E., Hahn, N. M., Regan, M. M., Werner, L., Alva, A., George, S., Picus, J., Alter, R., Balar, A., Hoffman-Censits, J., Grivas, P., Lauer, R., Guancial, E. A., Hoimes, C., Sonpavde, G., Albany, C., Stein, M. N., Breen, T., Jacobs, C., Anderson, K., & 4 othersBellmunt, J., Lalani, A. K. A., Pal, S. & Choueiri, T. K., May 1 2018, In: British journal of cancer. 118, 11, p. 1434-1441 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

14 Scopus citations

Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States

Pal, S. K., Hoffman-Censits, J., Zheng, H., Kaiser, C., Tayama, D. & Bellmunt, J., May 2018, In: European Urology. 73, 5, p. 800-806 7 p.

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer

Harshman, L. C., Tripathi, A., Kaag, M., Efstathiou, J. A., Apolo, A. B., Hoffman-Censits, J. H., Stadler, W. M., Yu, E. Y., Bochner, B. H., Skinner, E. C., Downs, T., Kiltie, A. E., Bajorin, D. F., Guru, K., Shipley, W. U., Steinberg, G. D., Hahn, N. M. & Sridhar, S. S., Jun 2018, In: Clinical Genitourinary Cancer. 16, 3, p. 213-218 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study

Myers, R. E., Leader, A. E., Censits, J. H., Trabulsi, E. J., Keith, S. W., Petrich, A. M., Quinn, A. M., Den, R. B., Hurwitz, M. D., Lallas, C. D., Hegarty, S. E., Dicker, A. P., Zeigler-Johnson, C. M., Giri, V. N., Ayaz, H. & Gomella, L. G., Feb 1 2018, In: Journal of Cancer Education. 33, 1, p. 180-185 6 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations

Pal, S. K., Rosenberg, J. E., Hoffman-Censits, J. H., Berger, R., Quinn, D. I., Galsky, M. D., Wolf, J., Dittrich, C., Keam, B., Delord, J. P., Schellens, J. H. M., Gravis, G., Medioni, J., Maroto, P., Sriuranpong, V., Charoentum, C., Burris, H. A., Grünwald, V., Petrylak, D., Vaishampayan, U., & 15 othersGez, E., De Giorgi, U., Lee, J. L., Voortman, J., Gupta, S., Sharma, S., Mortazavi, A., Vaughn, D. J., Isaacs, R., Parker, K., Chen, X., Yu, K., Porter, D., Porta, D. G. & Bajorin, D. F., Jul 2018, In: Cancer discovery. 8, 7, p. 812-821 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

105 Scopus citations

First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy

Valicenti, R. K., Pugh, S. L., Trabulsi, E. J., Sartor, O., Ko, E. C., Girvigian, M. R., Rosenthal, S. A., Shaves, M. E., Hoffman-Censits, J. H., Schallenkamp, J. & Sandler, H. M., Mar 1 2018, In: International Journal of Radiation Oncology Biology Physics. 100, 3, p. 695-701 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

5 Scopus citations

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial

Anari, F., O'Neill, J., Choi, W., Chen, D. Y. T., Haseebuddin, M., Kutikov, A., Dulaimi, E., Alpaugh, R. K., Devarajan, K., Greenberg, R. E., Bilusic, M., Wong, Y. N., Viterbo, R., Hoffman-Censits, J. H., Lallas, C. D., Trabulsi, E. J., Smaldone, M., Geynisman, D. M., Zibelman, M., Lin, J., & 4 othersKelly, W. K., Uzzo, R., McConkey, D. & Plimack, E. R., May 2018, In: European Urology Oncology. 1, 1, p. 54-60 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

16 Scopus citations

Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017

Giri, V. N., Knudsen, K. E., Kelly, W. K., Abida, W., Andriole, G. L., Bangma, C. H., Bekelman, J. E., Benson, M. C., Blanco, A., Burnett, A., Catalona, W. J., Cooney, K. A., Cooperberg, M., Crawford, D. E., Den, R. B., Dicker, A. P., Eggener, S., Fleshner, N., Freedman, M. L., Hamdy, F. C., & 50 othersHoffman-Censits, J., Hurwitz, M. D., Hyatt, C., Isaacs, W. B., Kane, C. J., Kantoff, P., Karnes, R. J., Karsh, L. I., Klein, E. A., Lin, D. W., Loughlin, K. R., Lu-Yao, G., Malkowicz, S. B., Mann, M. J., Mark, J. R., McCue, P. A., Miner, M. M., Morgan, T., Moul, J. W., Myers, R. E., Nielsen, S. M., Obeid, E., Pavlovich, C. P., Peiper, S. C., Penson, D. F., Petrylak, D., Pettaway, C. A., Pilarski, R., Pinto, P. A., Poage, W., Raj, G. V., Rebbeck, T. R., Robson, M. E., Rosenberg, M. T., Sandler, H., Sartor, O., Schaeffer, E., Schwartz, G. F., Shahin, M. S., Shore, N. D., Shuch, B., Soule, H. R., Tomlins, S. A., Trabulsi, E. J., Uzzo, R., Griend, D. J. V., Walsh, P. C., Weil, C. J., Wender, R. & Gomella, L. G., Feb 1 2018, In: Journal of Clinical Oncology. 36, 4, p. 414-424 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

87 Scopus citations

2017

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., Loriot, Y., Necchi, A., Hoffman-Censits, J., Perez-Gracia, J. L., Dawson, N. A., van der Heijden, M. S., Dreicer, R., Srinivas, S., Retz, M. M., Joseph, R. W., Drakaki, A., Vaishampayan, U. N., Sridhar, S. S., Quinn, D. I., & 15 othersDurán, I., Shaffer, D. R., Eigl, B. J., Grivas, P. D., Yu, E. Y., Li, S., Kadel, E. E., Boyd, Z., Bourgon, R., Hegde, P. S., Mariathasan, S., Thåström, A. C., Abidoye, O. O., Fine, G. D. & Bajorin, D. F., Jan 7 2017, In: The Lancet. 389, 10064, p. 67-76 10 p.

Research output: Contribution to journal › Article › peer-review

924 Scopus citations

Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: Post-progression outcomes from the phase II IMvigor210 study

Necchi, A., Joseph, R. W., Loriot, Y., Hoffman-Censits, J., Perez-Gracia, J. L., Petrylak, D. P., Derleth, C. L., Tayama, D., Zhu, Q., Ding, B., Kaiser, C. & Rosenberg, J. E., Dec 1 2017, In: Annals of Oncology. 28, 12, p. 3044-3050 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

65 Scopus citations

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies

Dan, T. D., Eldredge-Hindy, H. B., Hoffman-Censits, J., Lin, J., Kelly, W. K., Gomella, L. G., Lallas, C. D., Trabulsi, E. J., Hurwitz, M. D., Dicker, A. P. & Den, R. B., 2017, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 40, 4, p. 342-347 6 p.

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Jeannie Hoffman-Censits

Research output

Search results